Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer
Cervical Cancer, Endometrial Cancer, Fallopian Tube Cancer
About this trial
This is an interventional supportive care trial for Cervical Cancer focused on measuring stage IVA cervical cancer, stage IVB cervical cancer, fallopian tube cancer, stage IV ovarian epithelial cancer, stage IV ovarian germ cell tumor, ovarian sarcoma, ovarian stromal cancer, stage IV endometrial carcinoma, stage IV uterine sarcoma, stage IVA vaginal cancer, stage IVB vaginal cancer, stage IV vulvar cancer
Eligibility Criteria
DISEASE CHARACTERISTICS:
Histologically confirmed gynecological cancer
- Currently receiving first-line chemotherapy for metastatic disease
PATIENT CHARACTERISTICS:
- WHO performance status (PS) 0-2 or Karnofsky PS 70-100%
- Not pregnant or nursing
- Intake < 75% of theoretical need
- Weight loss ≥ 5% within the past 6 months
- No patients with dementia or altered mental status
- No psychological, familial, social, or geographic situations that preclude clinical follow up
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
- No concurrent radiotherapy
Sites / Locations
- Centre Oscar LambretRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
No Intervention
Experimental
Experimental
Arm I
Arm II
Arm III
Patients are monitored via standard follow-up assessments every 3 weeks.
Patients receive nutritional supplements and are monitored via standard follow-up assessments every 3 weeks.
Patients receive nutritional supplements and are monitored via standard follow-up assessments every 3 weeks with additional biweekly assessments completed at home by a service provider.